David A. Cameron

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.

L. Esserman, C. Denkert, E. Provenzano, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45.

N. Aaronson, M. Sprangers, A. Bottomley, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial

S. Litière, H. Bonnefoi, D. Cameron, 2014, The Pharmacogenomics Journal.